Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4696188010 | Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | en | Synonym | Active | Case insensitive | SNOMED CT core |
4696189019 | Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Is a | Pyrimethamine and sulfadoxine only product in oral dose form | true | Inferred relationship | Some | ||
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has manufactured dose form | Tablet for oral suspension | true | Inferred relationship | Some | ||
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Plays role | Antimalarial therapeutic role | true | Inferred relationship | Some | ||
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has precise active ingredient | Pyrimethamine | true | Inferred relationship | Some | 1 | |
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has BoSS | Pyrimethamine | true | Inferred relationship | Some | 1 | |
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has precise active ingredient | Sulfadoxine | true | Inferred relationship | Some | 2 | |
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has BoSS | Sulfadoxine | true | Inferred relationship | Some | 2 | |
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Pyrimethamine 12.5 mg and sulfadoxine 250 mg tablet for oral suspension | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets